Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2

Status

Completed 6

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Dermatologic 6

Conditions

Melanoma 1486Lymphoma, T-Cell, Cutaneous 313Skin Neoplasms 268Keratosis, Actinic 249Mycosis Fungoides 224Sezary Syndrome 216Lymphoma, Non-Hodgkin 206Leukemia, Lymphocytic, Chronic, B-Cell 200Lymphoma, Large B-Cell, Diffuse 198Lymphoma, Follicular 196Neoplasms 194Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Lymphoma, B-Cell, Marginal Zone 192Lymphoma, Mantle-Cell 191Hodgkin Disease 191Carcinoma, Basal Cell 190Breast Neoplasms 185Burkitt Lymphoma 184Lymphoma 182Lymphoma, Large-Cell, Immunoblastic 177Carcinoma, Non-Small-Cell Lung 150Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 140Lymphoma, Large-Cell, Anaplastic 137Multiple Myeloma 133Carcinoma, Renal Cell 128Immunoblastic Lymphadenopathy 126Uveal Melanoma 125Neoplasm Metastasis 120Leukemia, Myeloid, Acute 113Waldenstrom Macroglobulinemia 103

Interventions

3-ingenyl angelate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Melanosis × Dermatologic × Clear all
NCT06079619 2024-04-05

Comparison of Dermatoscopy X400 Interpreted by 6 Non-dermatologists and an Artificial Intelligence Software Skin Artificial Intelligence Versus Dermatoscopy x 20

Centre Hospitalier Universitaire de Saint Etienne

Completed
157 enrolled
Dermatologic

Melanoma, Melanosis, Neoplasms, Nevus

NCT04834167 2023-11-30

OneDoc Picopulseâ„¢ for the Treatment of Melasma Among Malaysian Women

Universiti Tunku Abdul Rahman

Phase NA Completed
32 enrolled
Dermatologic

Melanoma, Melanosis, Skin Diseases

NCT01444989 2018-08-15

AKRQ

Wake Forest University Health Sciences

Phase NA Completed
150 enrolled
Dermatologic

Melanosis, Keratosis, Actinic

NCT00375739 2016-01-28

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Peplin

Phase 2 Completed
200 enrolled
Dermatologic

Melanosis, Keratosis, Actinic

NCT00107965 2015-03-25

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses

Peplin

Phase 2 Completed
60 enrolled
Dermatologic

Melanosis, Keratosis, Actinic

NCT00239135 2015-03-25

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Peplin

Phase 2 Completed
34 enrolled
Dermatologic

Keratosis, Melanosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡